• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AERIN MEDICAL INC. RHINAER STYLUS; RADIOFREQUENCY PROBE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AERIN MEDICAL INC. RHINAER STYLUS; RADIOFREQUENCY PROBE Back to Search Results
Model Number FG1393
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Epistaxis (4458)
Event Date 12/24/2022
Event Type  Injury  
Event Description
(b)(6), 2022 the patient was taken to an ambulatory operating room where under general anesthesia the patient underwent a septoplasty, submucous resection of the inferior turbinates, a posterior nasal nerve ablation using the rhinaer stylus, and the left nasal septal swell body was treated.The septoplasty was performed first followed by treatment with rhinaer, and then the submucous resection of the turbinates.The procedure was uneventful with little intraoperative bleeding from any of the procedures.Visualization of the area of the posterior nasal nerves was not compromised by any of the adjunctive procedures.At one-week postoperative, the patient reported improved breathing.On (b)(6), 2022, the physician was contacted by an er stating that the patient had nasal bleeding.The er physicians packed the nose.Bleeding persisted and the patient was transferred to the physician's hospital and admitted.On (b)(6), 2022, the bleeding became severe, and a posterior nasal pack was placed along with rhinorocket nasal packs and a merocel nasal dressing.An interventional neuroradiologic evaluation was performed, it was unremarkable.During that procedure, the right sphenopalatine artery was embolized.The patient was intubated on (b)(6), 2022.The treating ent physician is uncertain why the patient was intubated however believes it was to manage the airway.The patient was extubated on (b)(6), 2022.The patient was discharged without problem and without any additional bleeding on (b)(6), 2023.The ent physician believes the bleeding may have occurred from a delayed separation of an eschar over the rhinaer treatment site.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RHINAER STYLUS
Type of Device
RADIOFREQUENCY PROBE
Manufacturer (Section D)
AERIN MEDICAL INC.
2565 leghorn st.
mountain view CA 94043
Manufacturer (Section G)
AERIN MEDICAL SINGAPORE PTE. LTD.
60 albert street #16-01
singapore 18996 9
SN   189969
Manufacturer Contact
shannon scott
2565 leghorn st.
mountain view, CA 94043
5122219956
MDR Report Key16281623
MDR Text Key308610118
Report Number3011625895-2023-00001
Device Sequence Number1
Product Code GEI
UDI-Device Identifier08886479300238
UDI-Public08886479300238
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K221907
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberFG1393
Device Catalogue NumberCAT1394
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age61 YR
Patient SexMale
-
-